Healio Minute
In this edition, FDA warns complications following radiofrequency microneedling device use, chronic hand eczema considered "common" disease, and more. Read the full coverage here: Q&A: FDA warns of radiofrequency microneedling risks; here's what to know [https://www.healio.com/news/dermatology/20251103/qa-fda-warns-of-radiofrequency-microneedling-risks-heres-what-to-know] Chronic hand eczema now considered a 'common' skin disease in US [https://www.healio.com/news/dermatology/20251107/chronic-hand-eczema-now-considered-a-common-skin-disease-in-us] 'Unproven' topical estrogens for the face may bring some risks [https://www.healio.com/news/dermatology/20251105/unproven-topical-estrogens-for-the-face-may-bring-some-risks] FDA approves Restylane Lyft to treat receding chin [https://www.healio.com/news/dermatology/20251111/fda-approves-restylane-lyft-to-treat-receding-chin] References Chovatiya R, et al. Prevalence of self-reported physician diagnosis of chronic hand eczema in adults: A cross-sectional study of more than 10,000 participants in the general population – Results from the CHECK study in the United States. Presented at: Fall Clinical Dermatology Conference; Oct. 23-26, 2025; Las Vegas. Farkas E, et al J Am Acad Dermatol. 2025;doi:10.1016/j.jaad.2025.08.050. [https://linkinghub.elsevier.com/retrieve/pii/S0190962225026763] Healio Interviews Press Release [https://www.galderma.com/news/galderma-receives-us-fda-approval-restylane-lyft]
153 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Healio Minute!